Citations (151)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (26)
Daniel W. Woodall, Thomas M. Dillon, Kevin Kalenian, Rupa Padaki, Scott Kuhns, David J. Semin & Pavel V. Bondarenko. (2022) Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry. mAbs 14:1.
Read now
Read now
Yu-Ling Wei, Teresa Wegesser, Scott Kuhns, Jonathan Werner, Hervé Lebrec & Xiaoting Wang. (2022) Strategies to evaluate potential effector function of glycan variants: A case study of ordesekimab (AMG 714 or PRV-015). Journal of Immunotoxicology 19:1, pages 109-116.
Read now
Read now
Harleen Kaur. (2021) Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development. Critical Reviews in Biotechnology 41:2, pages 300-315.
Read now
Read now
Richard J. Pleass. (2021) The therapeutic potential of sialylated Fc domains of human IgG. mAbs 13:1.
Read now
Read now
Thomas Kissner, Guenter Blaich, Andreas Baumann, Sven Kronenberg, Adam Hey, Andrea Kiessling, Petra M. Schmitt, Wouter Driessen, Chantal Carrez, Daniel Kramer, Jennifer Fretland, Wolfgang F. Richter, Tobias Paehler, Ulrike Hopfer & Benno Rattel. (2021) Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting. mAbs 13:1.
Read now
Read now
David Falck, Marco Thomann, Martin Lechmann, Carolien A. M. Koeleman, Sebastian Malik, Cordula Jany, Manfred Wuhrer & Dietmar Reusch. (2021) Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody. mAbs 13:1.
Read now
Read now
Allyson Kwiatkowski, Carl Co, Sei Kameoka, An Zhang, John Coughlin, Tom Cameron, Eric Chiao, Svetlana Bergelson & Cullen Schmid Mason. (2020) Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregates. mAbs 12:1.
Read now
Read now
Joschka Bauer, Sven Mathias, Sebastian Kube, Kerstin Otte, Patrick Garidel, Martin Gamer, Michaela Blech, Simon Fischer & Anne R Karow-Zwick. (2020) Rational optimization of a monoclonal antibody improves the aggregation propensity and enhances the CMC properties along the entire pharmaceutical process chain. mAbs 12:1.
Read now
Read now
Parimala Bolisetty, Gabi Tremml, Sen Xu & Anurag Khetan. (2020) Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies. mAbs 12:1.
Read now
Read now
Steffen Lippold, Simone Nicolardi, Elena Domínguez-Vega, Anna-Katharina Heidenreich, Gestur Vidarsson, Dietmar Reusch, Markus Haberger, Manfred Wuhrer & David Falck. (2019) Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry. mAbs 11:7, pages 1191-1196.
Read now
Read now
Shan Chung, Van Nguyen, Yuwen Linda Lin, Julien Lafrance-Vanasse, Suzie J. Scales, Kevin Lin, Rong Deng, Kathi Williams, Gizette Sperinde, Juan Jenny Li, Kai Zheng, Siddharth Sukumaran, Devin Tesar, James A. Ernst, Saloumeh Fischer, Greg A. Lazar, Saileta Prabhu & An Song. (2019) An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans. mAbs 11:5, pages 942-955.
Read now
Read now
Yingda Xu, Dongdong Wang, Bruce Mason, Tony Rossomando, Ning Li, Dingjiang Liu, Jason K Cheung, Wei Xu, Smita Raghava, Amit Katiyar, Christine Nowak, Tao Xiang, Diane D. Dong, Joanne Sun, Alain Beck & Hongcheng Liu. (2019) Structure, heterogeneity and developability assessment of therapeutic antibodies. mAbs 11:2, pages 239-264.
Read now
Read now
Ryuta Wada, Makoto Matsui & Nana Kawasaki. (2019) Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms. mAbs 11:2, pages 350-372.
Read now
Read now
Justin Bryan Goh & Say Kong Ng. (2018) Impact of host cell line choice on glycan profile. Critical Reviews in Biotechnology 38:6, pages 851-867.
Read now
Read now
Alexandre Ambrogelly, Stephen Gozo, Amit Katiyar, Shara Dellatore, Yune Kune, Ram Bhat, Joanne Sun, Ning Li, Dongdong Wang, Christine Nowak, Alyssa Neill, Gomathinayagam Ponniah, Cory King, Bruce Mason, Alain Beck & Hongcheng Liu. (2018) Analytical comparability study of recombinant monoclonal antibody therapeutics. mAbs 10:4, pages 513-538.
Read now
Read now
Gargi Roy, Tom Martin, Arnita Barnes, Jihong Wang, Rod Brian Jimenez, Megan Rice, Lina Li, Hui Feng, Shu Zhang, Raghothama Chaerkady, Herren Wu, Marcello Marelli, Diane Hatton, Jie Zhu & Michael A. Bowen. (2018) A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies. mAbs 10:3, pages 416-430.
Read now
Read now
Oliver Popp, Samuel Moser, Jörg Zielonka, Petra Rüger, Silke Hansen & Oliver Plöttner. (2018) Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function. mAbs 10:2, pages 290-303.
Read now
Read now
Neh Nupur, Nidhi Chhabra, Rozaleen Dash & Anurag S. Rathore. (2018) Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study. mAbs 10:1, pages 143-158.
Read now
Read now
Mark Hilliard, William R. Alley$suffix/text()$suffix/text(), Ciara A. McManus, Ying Qing Yu, Sinead Hallinan, John Gebler & Pauline M. Rudd. (2017) Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis. mAbs 9:8, pages 1349-1359.
Read now
Read now
Miroslav Dostalek, Thomayant Prueksaritanont & Robert F. Kelley. (2017) Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates. mAbs 9:5, pages 756-766.
Read now
Read now
Seokkyun Kim, Jinsu Song, Seungkyu Park, Sunyoung Ham, Kyungyeol Paek, Minjung Kang, Yunjung Chae, Heewon Seo, Hyung-Chan Kim & Michael Flores. (2017) Drifts in ADCC-related quality attributes of Herceptin®: Impact on development of a trastuzumab biosimilar. mAbs 9:4, pages 704-714.
Read now
Read now
Patrick Hossler, Christopher Chumsae, Christopher Racicot, David Ouellette, Alexander Ibraghimov, Daniel Serna, Alessandro Mora, Sean McDermott, Boris Labkovsky, Susanne Scesney, Christine Grinnell, Gregory Preston, Sahana Bose & Ralf Carrillo. (2017) Arabinosylation of recombinant human immunoglobulin-based protein therapeutics. mAbs 9:4, pages 715-734.
Read now
Read now
Kenta Haraya, Tatsuhiko Tachibana & Junichi Nezu. (2017) Predicting pharmacokinetic profile of therapeutic antibodies after iv injection from only the data after sc injection in cynomolgus monkey. Xenobiotica 47:3, pages 194-201.
Read now
Read now
Jenny Calow, Anna-Janina Behrens, Sonja Mader, Ulrike Bockau, Weston B. Struwe, David J. Harvey, Kai U. Cormann, Marc M. Nowaczyk, Karin Loser, Daniel Schinor, Marcus W.W. Hartmann & Max Crispin. (2016) Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity. mAbs 8:8, pages 1498-1511.
Read now
Read now
Lowell J Brady, Jyoti Velayudhan, Devi B Visone, Ken C Daugherty, Jeff L Bartron, Michael Coon, Cabot Cornwall, Peter J Hinckley & Lisa Connell-Crowley. (2015) The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development. mAbs 7:3, pages 562-570.
Read now
Read now
Kenta Haraya, Tatsuhiko Tachibana, Masahiko Nanami & Masaki Ishigai. (2014) Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody. Xenobiotica 44:12, pages 1127-1134.
Read now
Read now
Articles from other publishers (125)
Hayli A. Larsen, William M. Atkins & Abhinav Nath. (2023)
The origins of nonideality exhibited by monoclonal antibodies and
Fab
fragments in human serum
. Protein Science 32:12.
Crossref
Crossref
Benjamin P. M. Lake & Anthony F. Rullo. (2023) Offsetting Low-Affinity Carbohydrate Binding with Covalency to Engage Sugar-Specific Proteins for Tumor-Immune Proximity Induction. ACS Central Science 9:11, pages 2064-2075.
Crossref
Crossref
Frances Rocamora, Angelo G. Peralta, Seunghyeon Shin, James Sorrentino, Mina Ying Min Wu, Eric A. Toth, Thomas R. Fuerst & Nathan E. Lewis. (2023) Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies. Biotechnology Advances 67, pages 108206.
Crossref
Crossref
M. Svecla, J. Nour, M.R. Bladergroen, S. Nicolardi, T. Zhang, G. Beretta, M. Wuhrer, G.D. Norata & D. Falck. (2023) Impact of Asialoglycoprotein Receptor and Mannose Receptor Deficiency on Murine Plasma N-glycome Profiles. Molecular & Cellular Proteomics 22:9, pages 100615.
Crossref
Crossref
Gaurang P Bhide, Natalie E Bohrer, Danying Song, Jeanne Cabel, Marc R Lake, John E Harlan & Laura J Miesbauer. (2023) Novel method to specifically determine the structures of non-N297 glycans in IgGs. Glycobiology 33:5, pages 364-368.
Crossref
Crossref
Joel Welch, Cristina Ausin, Nina Brahme, Emanuela Lacana, Stacey Ricci & Marlene Schultz‐DePalo. (2022) The Mannose in the Mirror: A Reflection on the Pharmacokinetic Impact of High Mannose Glycans of Monoclonal Antibodies in Biosimilar Development. Clinical Pharmacology & Therapeutics 113:5, pages 1003-1010.
Crossref
Crossref
Jill L. Kinzer, Troy A. Halseth, Jukyung Kang, Sang Yeop Kim, Preethi Kumaran, Michael Ford, Sergei Saveliev, St John Skilton & Anna Schwendeman. (2023) Physicochemical characterization and functionality comparison of Humira®(adalimumab), Remicade®(infliximab) and Simponi Aria® (golimumab). International Journal of Pharmaceutics 635, pages 122646.
Crossref
Crossref
Mar Castellanos, Dolores Fernández-Couto, Andrés Da Silva-Candal, Maria J. Feal-Painceiras, Manuel Rodríguez-Yáñez, Carme Gubern-Mérida & Juan M. Sanchez. (2023) Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment. Separations 10:1, pages 34.
Crossref
Crossref
Yoshimi Haga, Masaki Yamada, Risa Fujii, Naomi Saichi, Takashi Yokokawa, Toshihiro Hama, Yoshihiro Hayakawa & Koji Ueda. (2022) Fast and Ultrasensitive Glycoform Analysis by Supercritical Fluid Chromatography–Tandem Mass Spectrometry. Analytical Chemistry 94:46, pages 15948-15955.
Crossref
Crossref
Sen Yang, Ming Cui, Qiaofei Liu & Quan Liao. (2022) Glycosylation of immunoglobin G in tumors: Function, regulation and clinical implications. Cancer Letters 549, pages 215902.
Crossref
Crossref
Jianan Feng, Linlin Jiang, Yiqing Cao, Chunhui Deng & Yan Li. (2022) Tractable Method for Rapid Quality Assessment of Therapeutic Antibodies in Harvested Cell Culture Fluid based on FcγRIIIa-Immobilized Magnetic Microspheres. Analytical Chemistry 94:33, pages 11492-11499.
Crossref
Crossref
Babette Wolf, Mateusz Piksa, Isabelle Beley, Agnes Patoux, Thierry Besson, Valerie Cordier, Bernd Voedisch, Patrick Schindler, Daniela Stöllner, Ludovic Perrot, Stephan von Gunten, Dominique Brees & Michael Kammüller. (2022) Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity. Immunology 166:3, pages 380-407.
Crossref
Crossref
Shufang Liu & Dhaval K. Shah. (2022) Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics. Drug Metabolism and Disposition 50:6, pages 867-878.
Crossref
Crossref
Elizabeth Edwards, Maria Livanos, Anja Krueger, Anne Dell, Stuart M. Haslam, C. Mark Smales & Daniel G. Bracewell. (2022) Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation. Biotechnology and Bioengineering 119:6, pages 1343-1358.
Crossref
Crossref
Anuj Shrivastava, Srishti Joshi, Andras Guttman & Anurag S. Rathore. (2022) N-Glycosylation of monoclonal antibody therapeutics: A comprehensive review on significance and characterization. Analytica Chimica Acta 1209, pages 339828.
Crossref
Crossref
Dong Gao, Lei Nie, Junjie Yuan, Feng Hu, Zhenhua Wu, Qunhai Lin & Haibin Wang. (2022) Physicochemical and Functional Characterization of HS016, a Biosimilar of Adalimumab (Humira). Journal of Pharmaceutical Sciences 111:4, pages 1142-1151.
Crossref
Crossref
Pavlos Kotidis, Masue Marbiah, Roberto Donini, Itzcóatl A. Gómez, Ioscani Jimenez del Val, Stuart M. Haslam, Karen M. Polizzi & Cleo Kontoravdi. 2022. Glycosylation. Glycosylation
147
167
.
Markus Schulze, Julia Niemann, Rene H. Wijffels, Jens Matuszczyk & Dirk E. Martens. (2021)
Rapid intensification of an established
CHO
cell fed‐batch process
. Biotechnology Progress 38:1.
Crossref
Crossref
Kirsty Skeene, Kshitij Khatri, Zoja Soloviev & Cris Lapthorn. (2021) Current status and future prospects for ion-mobility mass spectrometry in the biopharmaceutical industry. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1869:12, pages 140697.
Crossref
Crossref
Shasha Li, Alex J. McCraw, Richard A. Gardner, Daniel I.R. Spencer, Sophia N. Karagiannis & Gerd K. Wagner. (2021) Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors. Antibodies 10:4, pages 44.
Crossref
Crossref
Pavlos Kotidis, Iosif Pappas, Styliana Avraamidou, Efstratios N. Pistikopoulos, Cleo Kontoravdi & Maria M. Papathanasiou. (2021) DigiGlyc: A hybrid tool for reactive scheduling in cell culture systems. Computers & Chemical Engineering 154, pages 107460.
Crossref
Crossref
Cho Eun Kang, Seungeun Lee, Dong Hye Seo, Woon Heo, Sun Hyung Kwon, JeongRyeol Kim, Jinu Lee, Byoung Joon Ko, Hisashi Koiwa, Woo Taek Kim & Joo Young Kim. (2021) Comparison of CD20 Binding Affinities of Rituximab Produced in Nicotiana benthamiana Leaves and Arabidopsis thaliana Callus. Molecular Biotechnology 63:11, pages 1016-1029.
Crossref
Crossref
Anjali Shenoy, Srisaimaneesh Yalamanchili, Alexander R. Davis & Adam W. Barb. (2021) Expression and Display of Glycoengineered Antibodies and Antibody Fragments with an Engineered Yeast Strain. Antibodies 10:4, pages 38.
Crossref
Crossref
Shahid Rameez, Yogender K. Gowtham, Gautam Nayar & Sigma S. Mostafa. (2021)
Modulation of high mannose levels in
N
‐linked glycosylation through cell culture process conditions to increase antibody‐dependent cell‐mediated cytotoxicity activity for an antibody biosimilar
. Biotechnology Progress 37:5.
Crossref
Crossref
Fiammetta Di Marco, Thomas Berger, Wolfgang Esser-Skala, Erdmann Rapp, Christof Regl & Christian G. Huber. (2021) Simultaneous Monitoring of Monoclonal Antibody Variants by Strong Cation-Exchange Chromatography Hyphenated to Mass Spectrometry to Assess Quality Attributes of Rituximab-Based Biotherapeutics. International Journal of Molecular Sciences 22:16, pages 9072.
Crossref
Crossref
Tejinder Kaur, Bhupendra Nath Shukla, Vinay Kumar Yadav, Mahesh J. Kulkarni & Alka Rao. (2021) Comparison of glycoprofiles of rituximab versions licensed for sale in India and an analytical approach for quality assessment. Journal of Proteomics 244, pages 104267.
Crossref
Crossref
Zhenduo Shen, Yanhong Wang, Huarong Xu, Qian Zhang, Chunjie Sha, Baiping Sun & Qing Li. (2021) Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate. International Journal of Biological Macromolecules 180, pages 494-509.
Crossref
Crossref
Roberto DoniniStuart M. HaslamCleo Kontoravdi. (2021) Glycoengineering Chinese hamster ovary cells: a short history. Biochemical Society Transactions 49:2, pages 915-931.
Crossref
Crossref
Ella Fung, Liya Kang, Diana Sapashnik, Susan Benard, Annette Sievers, Yan Liu, Guoying Yan, Jing Zhou, Linette Rodriguez, Weijun Ma, Wayne R. Stochaj, Edward LaVallie, Liliana Wroblewska, Kerry Kelleher, Amy Tam, Olivier Bezy, Danna Breen, Jeffrey R. Chabot, Tao He, Laura Lin, Zhidan Wu & Lidia Mosyak. (2021) Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation. Scientific Reports 11:1.
Crossref
Crossref
Jian Xu, Zhihui Shao, Zhanqing Wang, Yingfeng Huang, Xun Zou & Yaling Shen. (2021) Developing a medium combination to attain similar glycosylation profile to originator by DoE and cluster analysis method. Scientific Reports 11:1.
Crossref
Crossref
Sudhakar Voruganti, Jiahui Xu, Xue Li, Gurusamy Balakrishnan, Surinder M. Singh, Sambit R. Kar & Tapan K. Das. (2021) A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology. Journal of Pharmaceutical Sciences 110:2, pages 935-945.
Crossref
Crossref
Gauri Pradhan, J.M. Sneha, Babasaheb P. Sonwane, B. Santhakumari, Alka Rao & Mahesh J. Kulkarni. (2021) Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs. Journal of Proteomics 232, pages 104053.
Crossref
Crossref
雪玲 居. (2021) Discussion on Characterization and Quality Control Strategies of Antibody N-Glycosylation. Pharmacy Information 10:03, pages 85-91.
Crossref
Crossref
Jingfu Zhao, Wenjing Peng, Xue Dong & Yehia Mechref. (2020) Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC–MS/MS-Based Glycoproteomic Approach. Journal of Proteome Research 20:1, pages 818-830.
Crossref
Crossref
Si Liu & Xin Liu. 2021.
1
47
.
Christoph Gstöttner, Harleen Kaur & Manfred Wuhrer. 2021. Monoclonal Antibodies. Monoclonal Antibodies
65
92
.
Itzcóatl Gómez Aquino & Ioscani Jiménez del Val. 2021. Cell Culture Engineering and Technology. Cell Culture Engineering and Technology
147
188
.
Xueqing Wang, Zhaohua Zhong, Lois Balmer & Wei Wang. 2021. The Role of Glycosylation in Health and Disease. The Role of Glycosylation in Health and Disease
321
339
.
Ximo Zhang. 2021. Proteomic Profiling. Proteomic Profiling
35
53
.
Hung Hiep Huynh, Naoki Morita, Toshihiro Sakamoto, Takuya Katayama, Takuya Miyakawa, Masaru Tanokura, Yasunori Chiba, Reiko Shinkura & Jun-ichi Maruyama. (2020) Functional production of human antibody by the filamentous fungus Aspergillus oryzae. Fungal Biology and Biotechnology 7:1.
Crossref
Crossref
Adriana Bajardi-Taccioli, Carl Co, Christine Bond, Allyson Masci, Tim Brantley, Chongfeng Xu, Svetlana Bergelson & Marina Feschenko. (2020) Biolayer Interferometry-based FcγRIIa binding assay for a therapeutic antibody with strong effector function. Analytical Biochemistry 611, pages 113842.
Crossref
Crossref
Neungseon Seo, Zhe Huang, Scott Kuhns, Heather Sweet, Shawn Cao, Mats Wikström & Jennifer Liu. (2020) Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product. Biologicals 68, pages 79-91.
Crossref
Crossref
Renato Mastrangeli, Maria Concetta Audino, Wolf Palinsky, Hervé Broly & Horst Bierau. (2020) The Formidable Challenge of Controlling High Mannose-Type N-Glycans in Therapeutic mAbs. Trends in Biotechnology 38:10, pages 1154-1168.
Crossref
Crossref
Xinhai Chen, Miaomiao ShiXin Tong, Hwan Keun KimLai-Xi Wang, Olaf SchneewindDominique Missiakas. (2020) Glycosylation-dependent opsonophagocytic activity of staphylococcal protein A antibodies. Proceedings of the National Academy of Sciences 117:37, pages 22992-23000.
Crossref
Crossref
Ximo Zhang, Corey E. Reed, Robert E. Birdsall, Ying Qing Yu & Weibin Chen. (2020) High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution. SLAS Technology 25:4, pages 380-387.
Crossref
Crossref
Yao Xu, Yang Xiao, Cheng Luo, Qingxia Liu, Aiqi Wei, Yang Yang, Liwen Zhao & Yong Wang. (2020) Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity. International Immunopharmacology 84, pages 106584.
Crossref
Crossref
Souad Boune, Peisheng Hu, Alan L. Epstein & Leslie A. Khawli. (2020) Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations. Antibodies 9:2, pages 22.
Crossref
Crossref
Natalia I. MajewskaMax L. TejadaMichael J. BetenbaughNitin Agarwal. (2020)
N-
Glycosylation of IgG and IgG-Like Recombinant Therapeutic Proteins: Why Is It Important and How Can We Control It?
. Annual Review of Chemical and Biomolecular Engineering 11:1, pages 311-338.
Crossref
Crossref
Jean-François Bruxelle, Tess Kirilenko, Quratulain Qureshi, Naiomi Lu, Nino Trattnig, Paul Kosma & Ralph Pantophlet. (2020) Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies. Scientific Reports 10:1.
Crossref
Crossref
Carina C.D. Joe, Sayantani Chatterjee, George Lovrecz, Timothy E. Adams, Morten Thaysen-Andersen, Renae Walsh, Stephen A. Locarnini, Peter Smooker & Hans J. Netter. (2020) Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity. Vaccine 38:22, pages 3892-3901.
Crossref
Crossref
Dung N. Nguyen, Richard L. Redman, Satoru Horiya, Jennifer K. Bailey, Bokai Xu, Robyn L. Stanfield, J. Sebastian Temme, Celia C. LaBranche, Shiyu Wang, Avital A. Rodal, David C. Montefiori, Ian A. Wilson & Isaac J. Krauss. (2020) The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans. ACS Chemical Biology 15:3, pages 789-798.
Crossref
Crossref
Ziyan Wang, Jianwei Zhu & Huili Lu. (2020) Antibody glycosylation: impact on antibody drug characteristics and quality control. Applied Microbiology and Biotechnology 104:5, pages 1905-1914.
Crossref
Crossref
Patricia A. Blundell, Dongli Lu, Anne Dell, Stuart Haslam & Richard J. Pleass. (2020) Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses. The Journal of Immunology 204:4, pages 1022-1034.
Crossref
Crossref
Sebastian Giehring. 2020. Animal Cell Biotechnology. Animal Cell Biotechnology
271
284
.
David N. Powers, Nicholas Trunfio, Sai R. Velugula‐Yellela, Phillip Angart, Anneliese Faustino & Cyrus Agarabi. (2019) Multivariate data analysis of growth medium trends affecting antibody glycosylation. Biotechnology Progress 36:1.
Crossref
Crossref
Simone Schadt, Simon Hauri, Filipe Lopes, Martin R. Edelmann, Roland F. Staack, Roberto Villaseñor, Hubert Kettenberger, Adrian B. Roth, Franz Schuler, Wolfgang F. Richter & Christoph Funk. (2019) Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug Metabolism and Disposition 47:12, pages 1443-1456.
Crossref
Crossref
Steffen Lippold, Simone Nicolardi, Manfred Wuhrer & David Falck. (2019) Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties. Frontiers in Chemistry 7.
Crossref
Crossref
Kuhne, Bonnington, Malik, Thomann, Avenal, Wegele, Reusch, Mormann, Bulau & Cymer. (2019) The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange. Antibodies 8:4, pages 49.
Crossref
Crossref
Lei Nie, Dong Gao, Haiyan Jiang, Jinxia Gou, Lei Li, Feng Hu, Tingting Guo, Haibin Wang & Haibin Qu. (2019) Development and Qualification of a Scale-Down Mammalian Cell Culture Model and Application in Design Space Development by Definitive Screening Design. AAPS PharmSciTech 20:6.
Crossref
Crossref
Naoki Kotani, Koichiro Yoneyama, Nobuhiko Kawakami, Tohru Shimuta, Hiroyuki Fukase & Takehiko Kawanishi. (2018) Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers. Clinical Pharmacology in Drug Development 8:6, pages 702-712.
Crossref
Crossref
Pavlos Kotidis, Philip Jedrzejewski, Si Nga Sou, Christopher Sellick, Karen Polizzi, Ioscani Jimenez del Val & Cleo Kontoravdi. (2019) Model‐based optimization of antibody galactosylation in CHO cell culture. Biotechnology and Bioengineering 116:7, pages 1612-1626.
Crossref
Crossref
Pavlos Kotidis, Panagiotis Demis, Cher H. Goey, Elisa Correa, Calum McIntosh, Stefania Trepekli, Nilay Shah, Oleksiy V. Klymenko & Cleo Kontoravdi. (2019) Constrained global sensitivity analysis for bioprocess design space identification. Computers & Chemical Engineering 125, pages 558-568.
Crossref
Crossref
Mats Carlsson, Martin Braddock, Yuling Li, Jihong Wang, Weichen Xu, Nicholas White, Ayman Megally, Gillian Hunter & Gene Colice. (2019) Evaluation of Antibody Properties and Clinically Relevant Immunogenicity, Anaphylaxis, and Hypersensitivity Reactions in Two Phase III Trials of Tralokinumab in Severe, Uncontrolled Asthma. Drug Safety 42:6, pages 769-784.
Crossref
Crossref
Lynn Kamen, Srividya Myneni, Chris Langsdorf, Elviza Kho, Benjamin Ordonia, Tara Thakurta, Kai Zheng, An Song & Shan Chung. (2019) A novel method for determining antibody-dependent cellular phagocytosis. Journal of Immunological Methods 468, pages 55-60.
Crossref
Crossref
Lynn Kamen, Tara Thakurta, Srividya Myneni, Kai Zheng & Shan Chung. (2019) Development of a kinetic antibody-dependent cellular cytotoxicity assay. Journal of Immunological Methods 468, pages 49-54.
Crossref
Crossref
David Brühlmann, Thomas Vuillemin, Abhijeet Satwekar, Eugenio Galano, Angelo Palmese, Alessandra D'Angelo, Zeynep Manco, Jonathan Souquet, Hervé Broly, Markus Sauer, Jürgen Hemberger & Martin Jordan. (2019) Generation of site‐distinct N‐glycan variants for in vitro bioactivity testing. Biotechnology and Bioengineering 116:5, pages 1017-1028.
Crossref
Crossref
Qun Zhou & Huawei Qiu. (2019) The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins. Journal of Pharmaceutical Sciences 108:4, pages 1366-1377.
Crossref
Crossref
Mathilde Bas, Aurélie Terrier, Emilie Jacque, Aurélie Dehenne, Virginie Pochet-Béghin, Cécile Beghin, Anne-Sophie Dezetter, Gilles Dupont, Anaïs Engrand, Benjamin Beaufils, Philippe Mondon, Nathalie Fournier, Christophe de Romeuf, Sylvie Jorieux, Alexandre Fontayne, Lennart T. Mars & Céline Monnet. (2019) Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies. The Journal of Immunology 202:5, pages 1582-1594.
Crossref
Crossref
Douglas Leipold & Saileta Prabhu. (2018) Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies. Clinical and Translational Science 12:2, pages 130-139.
Crossref
Crossref
David Reinhart, Lukas Damjanovic, Christian Kaisermayer, Wolfgang Sommeregger, Andreas Gili, Bernhard Gasselhuber, Andreas Castan, Patrick Mayrhofer, Clemens Grünwald-Gruber & Renate Kunert. (2019) Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass Synthesis. Biotechnology Journal 14:3, pages 1700686.
Crossref
Crossref
Dung N. Nguyen, Bokai Xu, Robyn L. Stanfield, Jennifer K. Bailey, Satoru Horiya, J. Sebastian Temme, Deborah R. Leon, Celia C. LaBranche, David C. Montefiori, Catherine E. Costello, Ian A. Wilson & Isaac J. Krauss. (2019) Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities. ACS Central Science 5:2, pages 237-249.
Crossref
Crossref
Alain Beck & Hongcheng Liu. (2019) Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies. Antibodies 8:1, pages 18.
Crossref
Crossref
Vally Kommineni, Matthew Markert, Zhongjie Ren, Sreenath Palle, Berenice Carrillo, Jasmine Deng, Armando Tejeda, Somen Nandi, Karen A. McDonald, Sylvain Marcel & Barry Holtz. (2019) In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants. International Journal of Molecular Sciences 20:1, pages 194.
Crossref
Crossref
Xing Jing, Yan Hou, William Hallett, Chandrahas G. Sahajwalla & Ping Ji. 2019. Therapeutic Enzymes: Function and Clinical Implications. Therapeutic Enzymes: Function and Clinical Implications
115
129
.
Chong-Feng Xu, Yan Wang, Pete Bryngelson, Zoran Sosic & Li Zang. 2019. Advancements of Mass Spectrometry in Biomedical Research. Advancements of Mass Spectrometry in Biomedical Research
225
236
.
Maureen Spearman, Erika Lattová, Hélène Perreault & Michael Butler. 2018. Bioprocessing Technology for Production of Biopharmaceuticals and Bioproducts. Bioprocessing Technology for Production of Biopharmaceuticals and Bioproducts
71
130
.
Cleo Kontoravdi & Ioscani Jimenez del Val. (2018) Computational tools for predicting and controlling the glycosylation of biopharmaceuticals. Current Opinion in Chemical Engineering 22, pages 89-97.
Crossref
Crossref
Matthew J. Buettner, Sagar R. Shah, Christopher T. Saeui, Ryan Ariss & Kevin J. Yarema. (2018) Improving Immunotherapy Through Glycodesign. Frontiers in Immunology 9.
Crossref
Crossref
Yanli Zhuang, Di Chen, Amarnath Sharma & Zhenhua Xu. (2018) Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective. The AAPS Journal 20:6.
Crossref
Crossref
Thomas Amann, Anders Holmgaard Hansen, Stefan Kol, Gyun Min Lee, Mikael Rørdam Andersen & Helene Faustrup Kildegaard. (2018)
CRISPR/Cas9-Multiplexed Editing of Chinese Hamster Ovary B4Gal-T1, 2, 3, and 4 Tailors
N
-Glycan Profiles of Therapeutics and Secreted Host Cell Proteins
. Biotechnology Journal 13:10, pages 1800111.
Crossref
Crossref
Matthew Stuible, Alina Burlacu, Sylvie Perret, Denis Brochu, Béatrice Paul-Roc, Jason Baardsnes, Martin Loignon, Eric Grazzini & Yves Durocher. (2018) Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells. Journal of Biotechnology 281, pages 39-47.
Crossref
Crossref
Sagit Shalel Levanon, Orit Aharonovitz, Ayelet Maor-Shoshani, Gita Abraham, Dan Kenett & Yehoshua Aloni. (2018) An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin. Journal of Biotechnology 276-277, pages 54-62.
Crossref
Crossref
Young Min Kim, Jin Se Park, Sang Kyung Kim, Kyung Min Jung, Young Sun Hwang, Mookyoung Han, Hong Jo Lee, Hee Won Seo, Jeong-Yong Suh, Beom Ku Han & Jae Yong Han. (2018) The transgenic chicken derived anti-CD20 monoclonal antibodies exhibits greater anti-cancer therapeutic potential with enhanced Fc effector functions. Biomaterials 167, pages 58-68.
Crossref
Crossref
Qiong Wang, Cheng-Yu Chung, Sandra Chough & Michael J. Betenbaugh. (2018) Antibody glycoengineering strategies in mammalian cells. Biotechnology and Bioengineering 115:6, pages 1378-1393.
Crossref
Crossref
Gaëtan Vanier, Szymon Stelter, Jessica Vanier, Franziska Hempel, Uwe G. Maier, Patrice Lerouge, Julian Ma & Muriel Bardor. (2018) Alga-Made Anti-Hepatitis B Antibody Binds to Human Fcγ Receptors. Biotechnology Journal 13:4, pages 1700496.
Crossref
Crossref
Florian Cymer, Hermann Beck, Adelheid Rohde & Dietmar Reusch. (2018) Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential. Biologicals 52, pages 1-11.
Crossref
Crossref
Ross A. McKinnon, Matthew Cook, Winston Liauw, Mona Marabani, Ian C. Marschner, Nicolle H. Packer & Johannes B. Prins. (2018) Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review. BioDrugs 32:1, pages 27-52.
Crossref
Crossref
Liming Liu. (2017) Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins. Protein & Cell 9:1, pages 15-32.
Crossref
Crossref
Ishan S. Shah, Scott Lovell, Nurjahan Mehzabeen, Kevin P. Battaile & Thomas J. Tolbert. (2017) Structural characterization of the Man5 glycoform of human IgG3 Fc. Molecular Immunology 92, pages 28-37.
Crossref
Crossref
Wei Wang, Brian Soriano & Qing Chen. (2017) Glycan profiling of proteins using lectin binding by Surface Plasmon Resonance. Analytical Biochemistry 538, pages 53-63.
Crossref
Crossref
Josiah T. Ryman & Bernd Meibohm. (2017) Pharmacokinetics of Monoclonal Antibodies. CPT: Pharmacometrics & Systems Pharmacology 6:9, pages 576-588.
Crossref
Crossref
Hongcheng Liu, Christine Nowak, Bruce Andrien, Mei Shao, Gomathinayagam Ponniah & Alyssa Neill. (2017) Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy. Biotechnology Progress 33:5, pages 1173-1181.
Crossref
Crossref
Nina K. Jain, Susan Barkowski-Clark, Richard Altman, Krista Johnson, Fang Sun, Jonathan Zmuda, Chao Yan Liu, Adriana Kita, Ryan Schulz, Alyssa Neill, Robert Ballinger, Rekha Patel, Jian Liu, Alinafe Mpanda, Brian Huta, Henry Chiou, Walter Voegtli & Tadas Panavas. (2017) A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293. Protein Expression and Purification 134, pages 38-46.
Crossref
Crossref
David J. Harvey. (2017) Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012. Mass Spectrometry Reviews 36:3, pages 255-422.
Crossref
Crossref
Cheng Luo, Song Chen, Na Xu, Chi Wang, Wen bo Sai, Wei Zhao, Ying chun Li, Xiao jing Hu, Hong Tian, Xiang dong Gao & Wen bing Yao. (2017) Glycoengineering of pertuzumab and its impact on the pharmacokinetic/pharmacodynamic properties. Scientific Reports 7:1.
Crossref
Crossref
Roy Jefferis. 2017. Biosimilar Drug Product Development. Biosimilar Drug Product Development
109
150
.
Nikolay P. Nikolov & Marjorie A. Shapiro. (2017) An FDA perspective on the assessment of proposed biosimilar therapeutic proteins in rheumatology. Nature Reviews Rheumatology 13:2, pages 123-128.
Crossref
Crossref
Natalie Krahn, Maureen Spearman, Markus Meier, July Dorion-Thibaudeau, Matthew McDougall, Trushar R. Patel, Gregory De Crescenzo, Yves Durocher, Jörg Stetefeld & Michael Butler. (2017) Inhibition of glycosylation on a camelid antibody uniquely affects its FcγRI binding activity. European Journal of Pharmaceutical Sciences 96, pages 428-439.
Crossref
Crossref
Thomas K. Villiger, Ana?s Roulet, Arnaud P?rilleux, Matthieu Stettler, Herv? Broly, Massimo Morbidelli & Miroslav Soos. (2016) Controlling the time evolution of mAb N-linked glycosylation, Part I: Microbioreactor experiments. Biotechnology Progress 32:5, pages 1123-1134.
Crossref
Crossref
Jennifer Liu, Tamer Eris, Cynthia Li, Shawn Cao & Scott Kuhns. (2016) Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab. BioDrugs 30:4, pages 321-338.
Crossref
Crossref
John Coughlin, Allyson Masci, Robert S. Gronke, Svetlana Bergelson & Carl Co. (2016) A simple enzyme–substrate localized conjugation method to generate immobilized, functional glutathione S-transferase fusion protein columns for affinity enrichment. Analytical Biochemistry 505, pages 51-58.
Crossref
Crossref
Peter G. Slade, R. Guy Caspary, Shilpa Nargund & Chung-Jr Huang. (2016) Mannose metabolism in recombinant CHO cells and its effect on IgG glycosylation. Biotechnology and Bioengineering 113:7, pages 1468-1480.
Crossref
Crossref
Udayanath Aich, Jude Lakbub & Aston Liu. (2016)
State‐of‐the‐art technologies for rapid and high‐throughput sample preparation and analysis of
N
‐glycans from antibodies
. ELECTROPHORESIS 37:11, pages 1468-1488.
Crossref
Crossref
Jing Fang, Jason Richardson, Zhimei Du & Zhongqi Zhang. (2016) Effect of Fc-Glycan Structure on the Conformational Stability of IgG Revealed by Hydrogen/Deuterium Exchange and Limited Proteolysis. Biochemistry 55:6, pages 860-868.
Crossref
Crossref
Apurva S. More, Vishal M. Toprani, Solomon Z. Okbazghi, Jae H. Kim, Sangeeta B. Joshi, C. Russell Middaugh, Thomas J. Tolbert & David B. Volkin. (2016) Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms. Journal of Pharmaceutical Sciences 105:2, pages 588-601.
Crossref
Crossref
Paul Declerck, Mourad Farouk-Rezk & Pauline M. Rudd. (2015) Biosimilarity Versus Manufacturing Change: Two Distinct Concepts. Pharmaceutical Research 33:2, pages 261-268.
Crossref
Crossref
Dietmar Reusch & Max L Tejada. (2015) Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology 25:12, pages 1325-1334.
Crossref
Crossref
Fabian Higel, Andreas Seidl, Uwe Demelbauer, Margot Viertlboeck-Schudy, Vera Koppenburg, Ulrich Kronthaler, Fritz S?rgel & Wolfgang Frie?. (2015) N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical. Pharmaceutical Research 32:11, pages 3649-3659.
Crossref
Crossref
Craig Zupke, Lowell J. Brady, Peter G. Slade, Philip Clark, R. Guy Caspary, Brittney Livingston, Lisa Taylor, Kyle Bigham, Arvia E. Morris & Robert W. Bailey. (2015) Real-time product attribute control to manufacture antibodies with defined N-linked glycan levels. Biotechnology Progress 31:5, pages 1433-1441.
Crossref
Crossref
Jennifer D. Könitzer, Markus M. Müller, Germán Leparc, Martin Pauers, Jan Bechmann, Patrick Schulz, Jochen Schaub, Barbara Enenkel, Tobias Hildebrandt, Martin Hampel & Anne B. Tolstrup. (2015) A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation. Biotechnology Journal 10:9, pages 1412-1423.
Crossref
Crossref
Sandhya Pande, Ayu Rahardjo, Brittney Livingston & Mirna Mujacic. (2015) Monensin, a small molecule ionophore, can be used to increase high mannose levels on monoclonal antibodies generated by Chinese hamster ovary production cell-lines. Biotechnology and Bioengineering 112:7, pages 1383-1394.
Crossref
Crossref
Sohye Kang, Zhongqi Zhang, Jason Richardson, Bhavana Shah, Shivani Gupta, Chung-Jr Huang, Jinshu Qiu, Nicole Le, Henry Lin & Pavel V. Bondarenko. (2015) Metabolic markers associated with high mannose glycan levels of therapeutic recombinant monoclonal antibodies. Journal of Biotechnology 203, pages 22-31.
Crossref
Crossref
Liming Liu. (2015) Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins. Journal of Pharmaceutical Sciences 104:6, pages 1866-1884.
Crossref
Crossref
Chung-Jr Huang, Henry Lin & Jerry Xiaoming Yang. (2015) A robust method for increasing Fc glycan high mannose level of recombinant antibodies. Biotechnology and Bioengineering 112:6, pages 1200-1209.
Crossref
Crossref
Gomathinayagam Ponniah, Christine Nowak, Nidia Gonzalez, Dino Miano & Hongcheng Liu. (2015) Detection and Quantitation of Low Abundance Oligosaccharides in Recombinant Monoclonal Antibodies. Analytical Chemistry 87:5, pages 2718-2726.
Crossref
Crossref
Rinpei Niwa & Mitsuo Satoh. (2015) The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology. Journal of Pharmaceutical Sciences 104:3, pages 930-941.
Crossref
Crossref
Laura K. Hmiel, Kurt A. Brorson & Michael T. BoyneIIII. (2014) Post-translational structural modifications of immunoglobulin G and their effect on biological activity. Analytical and Bioanalytical Chemistry 407:1, pages 79-94.
Crossref
Crossref
Michael A Meehl & Terrance A Stadheim. (2014) Biopharmaceutical discovery and production in yeast. Current Opinion in Biotechnology 30, pages 120-127.
Crossref
Crossref
Helen H. Shi & Chetan T. Goudar. (2014) Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans. Biotechnology and Bioengineering 111:10, pages 1907-1919.
Crossref
Crossref
Yolande Rouiller, Arnaud Périlleux, Marie-Noëlle Vesin, Matthieu Stettler, Martin Jordan & Hervé Broly. (2014) Modulation of mAb quality attributes using microliter scale fed-batch cultures. Biotechnology Progress 30:3, pages 571-583.
Crossref
Crossref
Chris Barton, David Spencer, Sophia Levitskaya, Jinhua Feng, Reed Harris & Mark A. Schenerman. 2014. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 1. Monoclonal Antibody Therapeutics: Structure, Function, and Regulatory Space. State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 1. Monoclonal Antibody Therapeutics: Structure, Function, and Regulatory Space
69
98
.
Mohammad A. Alsenaidy, Jae Hyun Kim, Ranajoy Majumdar, David D. Weis, Sangeeta B. Joshi, Thomas J. Tolbert, C. Russell Middaugh & David B. Volkin. (2013) High-Throughput Biophysical Analysis and Data Visualization of Conformational Stability of an IgG1 Monoclonal Antibody After Deglycosylation. Journal of Pharmaceutical Sciences 102:11, pages 3942-3956.
Crossref
Crossref
Alain Beck, Elsa Wagner-Rousset, Daniel Ayoub, Alain Van Dorsselaer & Sarah Sanglier-Cianférani. (2012) Characterization of Therapeutic Antibodies and Related Products. Analytical Chemistry 85:2, pages 715-736.
Crossref
Crossref
Padma Kumar Narayanan, Rafael Ponce & Beth Hinkle. 2013. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
65
95
.
Thomas A. Bowden, Kavitha Baruah, Charlotte H. Coles, David J. Harvey, Xiaojie Yu, Byeong-Doo Song, David I. Stuart, A. Radu Aricescu, Christopher N. Scanlan, E. Yvonne Jones & Max Crispin. (2012) Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis. Journal of the American Chemical Society 134:42, pages 17554-17563.
Crossref
Crossref